Indo-Bangla Pharmaceuticals (DHA:IBP) EV-to-Revenue : (As of Apr. 30, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Indo-Bangla Pharmaceuticals EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Indo-Bangla Pharmaceuticals's enterprise value is BDT0.00 Mil. Indo-Bangla Pharmaceuticals does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Indo-Bangla Pharmaceuticals's EV-to-Revenue at this moment.

The historical rank and industry rank for Indo-Bangla Pharmaceuticals's EV-to-Revenue or its related term are showing as below:

DHA:IBP's EV-to-Revenue is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 2.32
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-30), Indo-Bangla Pharmaceuticals's stock price is BDT13.50. Indo-Bangla Pharmaceuticals does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Indo-Bangla Pharmaceuticals's PS Ratio at this moment.

Indo-Bangla Pharmaceuticals EV-to-Revenue Historical Data

The historical data trend for Indo-Bangla Pharmaceuticals's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indo-Bangla Pharmaceuticals EV-to-Revenue Chart

Indo-Bangla Pharmaceuticals Annual Data

Trend

EV-to-Revenue

Indo-Bangla Pharmaceuticals Semi-Annual Data

EV-to-Revenue

Competitive Comparison of Indo-Bangla Pharmaceuticals's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Indo-Bangla Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Indo-Bangla Pharmaceuticals's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Indo-Bangla Pharmaceuticals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Indo-Bangla Pharmaceuticals's EV-to-Revenue falls into.

Indo-Bangla Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Indo-Bangla Pharmaceuticals's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	0.000	/
	=

Indo-Bangla Pharmaceuticals (DHA:IBP) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Indo-Bangla Pharmaceuticals's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	13.50	/
	=

Indo-Bangla Pharmaceuticals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Indo-Bangla Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Indo-Bangla Pharmaceuticals (DHA:IBP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indo-Bangla Pharmaceuticals Ltd (DHA:IBP) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Plot No. 183, 6th Floor, Block B, Ahmed Akbar Sobhan Road, Bashundhara R/A, Baridhara, Dhaka, BGD, 1229

Website

http://www.indo-banglapharma.com

Indo-Bangla Pharmaceuticals Ltd is engaged in manufacturing, marketing and distribution of generic pharmaceuticals products which includes human drugs dosages form such as tablet, capsule, syrup, oral saline, suspension. The products of the company are sold in domestic market. The company has also applied for permission for production and selling of veterinary medicine.